Clal Biotech (CBI) Financial Statements

0 Followers

Clal Biotech Financial Overview

Clal Biotech's market cap is currently ₪50.98M. The company's EPS TTM is -0.397; its P/E ratio is -2.21; Clal Biotech is scheduled to report earnings on ―, and the estimated EPS forecast is ―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	₪ 835.00K	₪ 433.00K	₪ 104.00K	₪ 370.00K	₪ 224.00K
Gross Profit	₪ 364.00K	₪ -183.00K	₪ 104.00K	₪ 370.00K	₪ 224.00K
Operating Income	₪ -18.41M	₪ -6.34M	₪ -10.18M	₪ -27.42M	₪ -77.59M
EBITDA	₪ -19.83M	₪ -6.34M	₪ -24.02M	₪ 64.22M	₪ -55.08M
Net Income	₪ -13.32M	₪ -62.46M	₪ -31.05M	₪ -61.74M	₪ -89.58M
Balance Sheet
Cash & Short-Term Investments	₪ 1.69M	₪ 5.01M	₪ 13.36M	₪ 12.88M	₪ 53.05M
Total Assets	₪ 41.83M	₪ 67.69M	₪ 158.39M	₪ 182.69M	₪ 444.92M
Total Debt	₪ 17.75M	₪ 20.84M	₪ 35.76M	₪ 36.73M	₪ 11.68M
Net Debt	₪ 16.07M	₪ 16.89M	₪ 30.03M	₪ 1.90M	₪ -41.37M
Total Liabilities	₪ 18.95M	₪ 21.52M	₪ 36.98M	₪ 37.79M	₪ 106.55M
Stockholders' Equity	₪ 20.20M	₪ 36.63M	₪ 99.36M	₪ 126.03M	₪ 172.59M
Cash Flow
Free Cash Flow	₪ -4.07M	₪ -6.48M	₪ -8.52M	₪ -60.31M	₪ -42.92M
Operating Cash Flow	₪ -4.07M	₪ -6.48M	₪ -8.51M	₪ -59.04M	₪ -41.33M
Investing Cash Flow	₪ 2.70M	₪ 20.00M	₪ 7.66M	₪ -10.96M	₪ 79.18M
Financing Cash Flow	₪ -929.00K	₪ -15.55M	₪ -1.18M	₪ 20.05M	₪ -51.54M

Currency in ILS

Clal Biotech Earnings and Revenue History

Income Statement >

Clal Biotech Debt to Assets

Balance Sheet >

Clal Biotech Cash Flow

Cash Flow >

Clal Biotech Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >